- Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells. Nimmanapalli, R., Fuino, L., Stobaugh, C., Richon, V., Bhalla, K. Blood (2003)









